Histamine and tryptase in nasal lavage fluid after allergen challenge: Effect of 1 week of pretreatment with intranasal azelastine or systemic cetirizine

被引:28
作者
Jacobi, HH
Skov, PS
Poulsen, LK
Malling, HJ
Mygind, N
机构
[1] Natl Univ Hosp, Allergy Unit, Copenhagen, Denmark
[2] Aarhus Univ Hosp, Dept Resp Dis, DK-8000 Aarhus, Denmark
关键词
allergic rhinitis; nasal allergen challenge; nasal mucosa; histamine; tryptase; cetirizine; azelastine;
D O I
10.1016/S0091-6749(99)70418-5
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Antihistamines (H-1-receptor antagonists) act by competitive antagonism of histamine at H-1-receptors, In addition, high concentrations of some antihistamines inhibit allergen-induced histamine release from mast cells in vitro, Objective: The purpose of this study was to determine the effect of intranasal azelastine or systemic cetirizine (both potent antihistamines) on the allergen-induced release of mast-cell mediators from the human nasal mucosa in vivo. Methods: Patients allergic to birch pollen (n = 11)and control subjects not allergic to birch pollen (n = 5) were included in a randomized, double-blind, placebo-controlled, 3-way crossover study outside the pollen season. Each subject was treated with azelastine nasal spray 0.14 mg per nostril twice daily, cetirizine tablets 10 mg every day, or placebo for 1 week using a double-dummy design. At the end of each treatment period, nasal allergen challenges were performed, and the number of sneezes were counted. In addition, nasal lavage fluid was collected, and the-levels of mast-cell mediators (histamine and tryptase) were measured. Results: The allergen challenge of patients allergic to pollen produced sneezing and a significant increase in the Levels of histamine and tryptase. The challenge of subjects not allergic to pollen produced no such response. Azelastine and cetirizine significantly reduced allergen-induced sneezing and the associated increase in histamine and tryptase levels. No significant differences were found between the azelastine and cetirizine treatments. Conclusion: Pretreatment with azelastine or cetirizine inhibits the allergen-induced release of mast-cell mediators from the human nasal mucosa, Our results are consistent with the hypothesis that both antihistamines reduce mediator release from nasal mucosa mast cells in vivo. However, further studies are necessary to test this hypothesis.
引用
收藏
页码:768 / 772
页数:5
相关论文
共 28 条
[1]   MEASUREMENT OF HISTAMINE IN NASAL LAVAGE FLUID - COMPARISON OF A GLASS-FIBER BASED FLUOROMETRIC METHOD WITH 2 RADIOIMMUNOASSAYS [J].
ANDERSSON, M ;
NOLTE, H ;
OLSSON, M ;
SKOV, PS ;
PIPKORN, U .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1990, 86 (05) :815-820
[2]   SUPPRESSIVE EFFECT OF LORATADINE ON ALLERGEN-INDUCED HISTAMINE-RELEASE IN THE NOSE [J].
ANDERSSON, M ;
NOLTE, H ;
BAUMGARTEN, C ;
PIPKORN, U .
ALLERGY, 1991, 46 (07) :540-546
[3]   COMPARISON OF THE SECRETORY RESPONSE OF THE NASAL-MUCOSA TO METHACHOLINE AND HISTAMINE [J].
BAROODY, FM ;
WAGENMANN, M ;
NACLERIO, RM .
JOURNAL OF APPLIED PHYSIOLOGY, 1993, 74 (06) :2661-2671
[4]   ANTIALLERGIC ACTIVITY OF H1-RECEPTOR ANTAGONISTS ASSESSED BY NASAL CHALLENGE [J].
BOUSQUET, J ;
LEBEL, B ;
CHANAL, I ;
MOREL, A ;
MICHEL, FB .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1988, 82 (05) :881-887
[5]   INHIBITION OF HISTAMINE-RELEASE FROM HUMAN-LUNG INVITRO BY ANTIHISTAMINES AND RELATED DRUGS [J].
CHURCH, MK ;
GRADIDGE, CF .
BRITISH JOURNAL OF PHARMACOLOGY, 1980, 69 (04) :663-667
[6]   POSITION PAPER - ALLERGEN STANDARDIZATION AND SKIN-TESTS [J].
DREBORG, S ;
FREW, A .
ALLERGY, 1993, 48 (14) :49-82
[7]  
FALLIERS CJ, 1991, ANN ALLERGY, V66, P257
[8]   Loratadine and desethoxylcarbonyl-loratadine inhibit the immunological release of mediators from human Fc epsilon RI+ cells [J].
Genovese, A ;
Patella, V ;
DeCrescenzo, G ;
DePaulis, A ;
Spadaro, G ;
Marone, G .
CLINICAL AND EXPERIMENTAL ALLERGY, 1997, 27 (05) :559-567
[9]   LORATADINE REDUCES ALLERGEN-INDUCED MUCOSAL OUTPUT OF ALPHA(2)-MACROGLOBULIN AND TRYPTASE IN ALLERGIC RHINITIS [J].
GREIFF, L ;
PERSSON, CGA ;
SVENSSON, C ;
ENANDER, I ;
ANDERSSON, M .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1995, 96 (01) :97-103
[10]  
Jacobi HH, 1998, CLIN EXP ALLERGY, V28, P83